Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-25

Clinical Trial Update: Evaluation of CRS3123 vs. Oral Vancomycin in Adult Patients With Clostridioides Difficile Infection [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing CRS3123 to oral vancomycin for adult Clostridioides difficile infection has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CRS3123
  • oral vancomycin (vancomycin)

Snippet

Sponsor: Crestone, Inc | Conditions: Clostridioides Difficile Infection | Phase 2 | Status: COMPLETED | Results posted: 2025-05-25